WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.22 %Nav, as on 12-06-2025

  • Previous Nav

  • Net Change on 12-06-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 14.60 24.76 22.02 1.80 8,352.16
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 23.99 29.05 25.16 1.90 5,507.52
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 17.34 22.81 22.16 1.94 2,690.55
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 15.14 24.30 21.65 2.12 1,231.67
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 22.11 25.88 22.02 2.27 1,062.19

Fund Holdings as on 31-May-2025

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Cipla Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Krishna Institute Of Medical Sciences Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Eris Lifesciences Limited

  • Clearing Corporation of India Ltd

  • Emcure Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • IPCA Laboratories Limited

  • Abbott India Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Kovai Medical Center and Hospital Limited

  • Ajanta Pharma Limited

  • Shaily Engineering Plastics Limited

  • Jupiter Life Line Hospitals Limited

  • Neuland Laboratories Limited

  • Pfizer Limited

  • Thyrocare Technologies Limited

  • Strides Pharma Science Limited

  • Ami Organics Limited

  • Alembic Pharmaceuticals Limited

  • FDC Limited

  • 91 Days Tbill (MD 11/07/2025)

  • Global Health Limited

  • RPG Life Sciences Limited

  • 91 Days Tbill (MD 01/08/2025)

  • Supriya Lifescience Limited

  • Net Receivables / (Payables)

  • PB Fintech Limited

  • Laxmi Dental Limited

  • Navin Fluorine International Limited

  • Dr.Agarwals Eye Hospital Limited

  • Poly Medicure Limited

  • Blue Jet Healthcare Ltd

  • Jubilant Ingrevia Limited

  • Rainbow Childrens Medicare Limited

  • Aster DM Healthcare Limited

  • Vijaya Diagnostic Centre Limited

  • 91 Days Tbill (MD 19/06/2025)

  • 91 Days Tbill (MD 26/06/2025)

  • 364 Days Tbill (MD 28/08/2025)

  • Dr. Reddy's Laboratories Limited

  • 182 Days Tbill (MD 05/06/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sov

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹331.66 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended up ₹0.03(0.22%)yesterday to ₹13.372.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643